A robust evaluation of 49 high-dose-rate prostate brachytherapy treatment plans including all major uncertainties.

Andrew Christopher KennedyMichael John James DouglassAlexandre Manuel Caraça Santos

Published in: Journal of applied clinical medical physics (2023)

Assessing treatment plan robustness improves plan quality assurance, is achievable in less than 1-min, and identifies treatment plans with poor robustness, allowing re-optimization before delivery.

Keyphrases

high dose
radiation therapy
squamous cell carcinoma
health insurance
benign prostatic hyperplasia